Showing results (201-210 of 215) with videos related to
Sort By:
Pageof 22
Cellular Oncology (Dordrecht, Netherlands)|July 23, 2022
Novel protein kinase inhibitor TT-00420 inhibits gallbladder cancer by inhibiting JNK/JUN-mediated signaling pathwayHuijie Miao, Yajun Geng, Yang Li, et al.Signal Transduction and Targeted Therapy|March 20, 2026
SHR-A1811, a novel HER2-targeting antibody-drug conjugate, in advanced solid tumors (HORIZON-X): a global phase 1 trialHerui Yao, Min Yan, Zhongsheng Tong, et al.Cell Regeneration (London, England)|January 14, 2025
Standard: Human gastric organoidsFan Hong, Ronghui Tan, Ting Wang, et al.The Journal of Clinical Investigation|March 2, 2026
Macrophage-rich niches regulate T cell dynamics at the liver invasive margin during gallbladder cancer progressionMaolan Li, Zhaonan Liu, Shenbing Shan, et al.Cell Regeneration (London, England)|December 27, 2024
Standard: Human gastric cancer organoidsRonghui Tan, Fan Hong, Ting Wang, et al.Gut|June 30, 2018
Genomic <i>ERBB2</i>/<i>ERBB3</i> mutations promote PD-L1-mediated immune escape in gallbladder cancer: a whole-exome sequencing analysisMaolan Li, Fatao Liu, Fei Zhang, et al.Journal of Hepatology|June 25, 2021
Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancerYijian Zhang, Chunman Zuo, Liguo Liu, et al.Hepatology International|July 9, 2020
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseasesChihua Fang, Jihyun An, Antonio Bruno, et al.Cancer Cell|March 11, 2025
Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disordersMao Yang, Yuhao Zhao, Chen Li, et al.Bioscience Trends|August 13, 2025
Chinese multicenter expert consensus on the diagnosis and treatment of hilar cholangiocarcinoma: 2025 editionSulai Liu, Jinqiong Jiang, Qian Jian, et al.Pageof 22